COMMUNIQUÉS West-GlobeNewswire
-
ECM Therapeutics Receives FDA 510(k) Clearance for ECMT-100 WMD
23/06/2026 -
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
23/06/2026 -
Evaluate Releases Annual World Preview Report Revealing Updated Market Forecasts for the Pharmaceutical Industry
23/06/2026 -
Thousands of Free HIV Tests to Support National HIV Testing Day Activities Across the United States
23/06/2026 -
SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside
23/06/2026 -
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
23/06/2026 -
EssilorLuxottica et Meta étendent l’accès à la catégorie des wearables avec une nouvelle collection
23/06/2026 -
EssilorLuxottica and Meta expand the accessibility of wearables category with new collection
23/06/2026 -
Sigmatic Sciences Powers AI Scientists with NVIDIA’s Latest BioNeMo Agentic Capabilities
23/06/2026 -
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
23/06/2026 -
X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson's Disease Therapy
23/06/2026 -
Peptide Mind Launches Expanded Research Library and Educational Tools for Peptide Research Community
23/06/2026 -
Berry Street and Tia Partner to Deliver Clinical Nutrition Therapy at Every Stage of a Woman's Life
23/06/2026 -
Advanced Rehabilitation, LLC Expands iKNOT Curriculum to Address Complex Regional Pain Syndrome & Chronic Upper Extremity Problems
23/06/2026 -
Avalo Therapeutics Appoints Ron Philip to Board of Directors
23/06/2026 -
Soleo Health Named URAC Performance Measurement Pioneer for Second Consecutive Year
23/06/2026 -
Oryn Therapeutics Advances Next Phase of Orynotide™ Macrocyclic Peptide Platform Development with Expanded Leadership Team and Board Anchored by Accomplished Life Sciences Industry Veterans, Company Builders and Drug Developers
23/06/2026 -
Cytonus Therapeutics Becomes Axiom Biosciences, Pairing Its Regenerative Medicine Programs With AI-Enabled Drug Design
23/06/2026 -
UREVO Mid-Year Sale Brings 2026's Biggest Deal Yet to Amazon and Official Website
23/06/2026
Pages